/
Bettina Geidl, PhD Division of Endocrinology, Diabetes, and Clinical Nutrition Bettina Geidl, PhD Division of Endocrinology, Diabetes, and Clinical Nutrition

Bettina Geidl, PhD Division of Endocrinology, Diabetes, and Clinical Nutrition - PowerPoint Presentation

stella
stella . @stella
Follow
65 views
Uploaded On 2023-11-08

Bettina Geidl, PhD Division of Endocrinology, Diabetes, and Clinical Nutrition - PPT Presentation

University Hospital Zurich University of Zurich Fructose and sucrose but not glucosesweetened beverages promote hepatic de novo lipogenesis A randomized controlled trial J Hepatol 2021 Jul 7514654 ID: 1030459

fatty acid oxidation ssb acid fatty ssb oxidation novo 2h5 fructose glucose synthesis sugar disease intake randomized prof liver

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Bettina Geidl, PhD Division of Endocrino..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Bettina Geidl, PhDDivision of Endocrinology, Diabetes, and Clinical NutritionUniversity Hospital Zurich, University of ZurichFructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trialJ Hepatol. 2021 Jul. 75(1):46-54

2. Sugar intake – a risk factor for metabolic disease NAFLDAdded SugarObesityJensen et al. Fructose and Sugar: A Major Mediator of Nonalcoholic Fatty Liver Disease. Jhepal, 2018

3. Glucose vs fructose metabolism3 GlucoseFructoseInsulinDe novo lipogenesisFructoseGlucoseGlycogen70%KHK-C

4. Aim of the study / hypotheses SucroseFructoseGlucoseFatty acid synthesisLipolysisInsulin resistance?β oxidationLipogenic enzymes?Muscle?Liver?Free fatty acid effluxFood intakeLaboratory parametersOGTTAdipokines80g/day

5. Study design: randomized controlled trialGlucoseNo SSB (Control)FructoseSucrose94 healthy young men, BMI < 24 kg/m2Week 5Week 7Week 0FFA oxidationLipolysisFatty acid and TAG synthesis/secretion LipolysisOGTTDietary intakeOGTTDietary intakeWeek 6

6. Hepatic de novo fatty acid synthesisG6PFructoseChREBPSREBP1cXBP-1Lipogenic genesFatty acid synthesisFatty acidsTAGGlucoseFatty acid oxidation genesPPARα Fatty acid oxidationBeta oxidation

7. Measurement of fatty acid synthesis by Mass Isotopomer Distribution Analysis (MIDA)TAGVLDL[2H5] glycerolPreformed FA[1,2-13C] acetateglucosePalmitate IsotopomersM+0, M+2, M+4 Palmitatede novo FA[2H5]glycerolglycerol3x Fatty acidTAG

8. Consumption of fructose- and sucrose-SSB increases basal FA synthesis

9. Lipolysis and FA oxidationTriglycerideLipolysisFatty acidsβ oxidationβ oxidation[2H5]glycerolU-13C-palmitate

10. Effects of SSB consumption on dietary intake*

11. ********

12. Effects of SSB on secondary outcome parametersSucroseFructoseGlucoseGlucose metabolismOral Glucose ToleranceFasting glucoseFasting insulinBlood lipidsFasting TAGFasting cholesterolAdipokinesLeptinGlucoseFructoseSucroseLDL profileSmall dense LDLGlucoseFructoseSucrose

13. Summary

14. Prof. Dr. Luc TappyPD Dr. Harald KöfelerDr. Isabelle Herter-AeberliDr. med. Agota NemethPD Dr. Michel HochuliProf. Dr. Kaspar Berneis † Prof. Dr. Giatgen SpinasPD Dr. Philipp GerberClinical Trial Center USZPhilhuman FoundationPromedica FoundationDr. Anita Eberl